rabeprazole has been researched along with Neoplasm Metastasis in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falcone, R | 1 |
| Roberto, M | 1 |
| D'Antonio, C | 1 |
| Romiti, A | 1 |
| Milano, A | 1 |
| Onesti, CE | 1 |
| Marchetti, P | 1 |
| Fais, S | 1 |
1 other study available for rabeprazole and Neoplasm Metastasis
| Article | Year |
|---|---|
High-doses of proton pump inhibitors in refractory gastro-intestinal cancer: A case series and the state of art.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Colorectal Neoplasms; Humans; Male; Neoplasm Metastasis | 2016 |